Close

Arrowhead Research (ARWR) PT Lowered to $5 at Jefferies Following Clinical Hold

November 10, 2016 7:54 AM EST Send to a Friend
Jefferies analyst Eun Yang reiterated a Hold rating and cut his price target on Arrowhead Research (NASDAQ: ARWR) to $5.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login